Cite

HARVARD Citation

    Schneider, T. et al. (2016). (Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges. BMC cancer. 16 (1), pp. 1-6. [Online]. 
  
Back to record